In patients with definite NASH (NASH score ≥ 5), CMKLR1 mRNA was not significantly increased compared to controls and compared to patients with borderline NASH (NASH score < 5) (Figure 2A). Here, CMKLR1 is linked to metabolic dysfunction-associated steatohepatitis.